Impact of Roux-en-Y gastric bypass on lipid and inflammatory profiles;Impacto da derivação gástrica em Y-de-Roux no perfil inflamatório e lipídico

Revista do Colegio Brasileiro de Cirurgioes

Volumn 42, Issue 5, 2015, Pages 305-310

  Oliveira, Cleiton da Silva ^a   Beserra, Bruna Teles Soares ^a   Cunha, Raphael Salles Granato ^a   Brito, Ana Gabriela Estevam ^a   de Miranda, Rafaella Cristina Dimbarre ^a   Zeni, Lúcia Andréia Zanette Ramos ^a   Nunes, Everson Araújo ^a   Trindade, Erasmo Benicio Santos de Moraes ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Gastric bypass; Inflammation mediators; Obesity; Weight loss

Indexed keywords

C REACTIVE PROTEIN; LIPID;

ADULT; BLOOD; FEMALE; GASTRIC BYPASS SURGERY; HUMAN; MALE; MIDDLE AGED; OBESITY, MORBID; PROSPECTIVE STUDY; WEIGHT REDUCTION;

ADULT; C-REACTIVE PROTEIN; FEMALE; GASTRIC BYPASS; HUMANS; LIPIDS; MALE; MIDDLE AGED; OBESITY, MORBID; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 84949512140     PISSN: 01006991     EISSN: 18094546     Source Type: Journal    
DOI: 10.1590/0100-69912015005007     Document Type: Article

References (35)

1. World Health Organization [homepage na internet]. Fact sheet no 311: Facts about overweight and obesity. Acessado em: 15 mar 2013. Disponível em: http://www.who.int/mediacentre/factsheets/ fs311/en/
2. Francischi RPP, Pereira LO, Freitas CS, Klopfer M, Santos RC, Vieira P, et al. Obesidade: atualização sobre sua etiologia, morbidade e tratamento. Rev Nutr. 2000;13(1):17-28.
3. Pinheiro ARO, Freitas SFT, Corso ACT. Uma abordagem epidemiológica da obesidade. Rev Nutr. 2004;17(4):523-33.
4. World Health Organization. Obesity: prevention and management of the global epidemic. Reportof a WHO Consultation on Obesity. Geneva: WHO. 1998.
5. Abrantes MM, Lamounier JA, Colosimo EA. Prevalência de sobrepeso e obesidade nas regiões Nordeste e Sudeste do Brasil. Rev Assoc Med Bras. 2003;49(2):162-6.
6. Instituto Brasileiro de Geografia e Estatística. Pesquisa de orçamentos familiares 2008-2009. Antropometria e Estado Nutricional de Crianças, adolescentes e adultos no Brasil. Rio de Janeiro: IBGE, 2010.
7. Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica. Diretrizes Brasileiras de Obesidade 2009/2010 / ABESO - Associação Brasileira para o Estudo da obesidade e da Síndrome Metabólica. 3a ed. Itapevi, SP: AC Farmacêutica, 2009.
8. Brasil. Conselho Federal de Medicina. Resolução CFM no 1.942/ 2010. Normas seguras para o tratamento cirúrgico da obesidade mórbida, definindo indicações, procedimentos e equipe. Diário Oficial da União, 12 fev 2010; Seção I, p. 72.
9. Sociedade Brasileira de Cirurgia Bariátrica e Metabólica [homepage na internet]. Técnicas Cirúrgicas. Acessado em: 27 fev 2013. Disponível em: http://www.sbcbm.org.br/wordpress/tratamento- cirurgico/cirurgia-laparoscopica/
10. Bulló M, Casas-Agustench P, Amigó-Correig P, Aranceta J, Salas- Salvadó J. Inflammation, obesity and comorbidities: the role of diet. Public Health Nutr. 2007;10(10A):1164-72.
11. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448-54.
12. Morley JJ, Kushner I. Serum C-reactive protein levels in disease. Ann N Y Acad Sci. 1982;389:406-18.
13. World Health Organization [homepage na internet]. BMI classification, Geneve, Switzerland: World Health Organization, 2008 [acesso em 16 mar 2013]. Disponível em: http://apps.who.int/ bmi/index.jsp?introPage=intro_3.html
14. Lasky FD, Li ZM, Shaver DD, Savory J, Sarvory MG, Willey DG, et al. Evaluation of a bromocresol purple method for the determination of albumin adapted to the DuPont aca discrete clinical analyzer. Clin Biochem. 1985;18(5):290-6.
15. Ledue TB, Weiner DL, Sipe JD, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannosebinding protein in human serum. Ann Clin Biochem. 1998;35 (Pt 6):745-53.
16. Rautela GS, Liedtke RJ. Automated enzymic measurement of total cholesterol in serum. Clin Chem. 1978;24(1):108-14.
17. Rifai N, Russell Warnick G, Dominiczak MH. Handbook of Lipoprotein Testing. Washington, DC: AACC; 1997.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502.
19. Correa CR, Angeleli AYO, Camargo NR, Barbosa L, Burini RC. Comparação entre a relação PCR/albumina e o índice de prognóstico inflamatório nutricional (IPIN). J Bras Patol Med Lab. 2002;38(3):183- 90.
20. Holdstock C, Lind L, Engstrom BE, Ohrvall M, Sundbom M, Larsson A, et al. CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects. Int J Obes. 2005;29(10):1275-80.
21. João Cabrera E, Valezi AC, Delfino VD, Lavado EL, Barbosa DS. Reduction in plasma levels of inflammatory and oxidative stress indicators after Roux-en-Y gastric bypass. Obes Surg. 2010;20(1):42-9.
22. Miller GD, Nicklas BJ, Fernandez A. Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2011;7(5):618-24.
23. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88.
24. Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142(7):547-59.
25. Forsythe LK, Wallace JM, Livingstone MB. Obesity and inflammation: the effects of weight loss. Nutr Res Rev. 2008;21(2):117-33.
26. Pihlajamäki J, Grönlund S, Simonen M, Käkelä P, Moilanen L, Pääkkönen M, et al. Cholesterol absorption decreases after Rouxen- Y gastric bypass but not after gastric banding. Metabolism. 2010;59(6):866-72.
27. Pedrosa IV, Burgos MGPA, Souza NC, Morais CN. Aspectos nutricionais em obesos antes e após a cirurgia bariátrica. Rev Col Bras Cir. 2009;36(4):316-22.
28. Pardina E, Ferrer R, Baena-Fustegueras JA, Rivero J, Lecube A, Fort JM, et al. Only C-reactive protein, but not TNF-á or IL6, reflects the improvement in inflammation after bariatric surgery. Obes Surg. 2012;22(1):131-9.
29. Rojas P, Carrasco F, Codoceo J, Inostroza J, Basfi-fer K, Papapietro K, et al. Trace element status and inflammation parameters after 6 months of Roux-en-Y gastric bypass. Obes Surg. 2011;21(5):561- 8.
30. Selvin E, Paynter NP, Erlinger TP. The effect of weight loss on Creactive protein: a systematic review. Arch Intern Med. 2007;167(1):31-9.
31. Anty R, Dahman M, Iannelli A, Gual P, Staccini-Myx A, Amor IB, et al. Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammation. Obes Surg. 2008;18(6):709-14.
32. Iannelli A, Anty R, Piche T, Dahman M, Gual P, Tran A, et al. Impact of laparoscopic Roux-en-Y gastric bypass on metabolic syndrome, inflammation, and insulin resistance in super versus morbidly obese women. Obes Surg. 2009;19(5):577-82.
33. Santos NSJ, Draibe SA, Kamimura MA, Cuppari L. Albumina sérica como marcador nutricional de pacientes em hemodiálise. Rev Nutr. 2004;17(3):339-49.
34. Farias LM, Coêlho MPSS, Barbosa RF, Santos GS, Marreiro DN. Aspectos nutricionais em mulheres obesas submetidas à gastroplastia vertical com derivação gastro-jejunal em Y-de- Roux. Rev Bras Nutr Clin. 2006;21(2):98-103.
35. Nicoletti CF, Morandi Junqueira-Franco MV, dos Santos JE, Marchini JS, Salgado W Jr, Nonino CB. Protein and amino acid status before and after bariatric surgery: a 12-month follow-up study. Surg Obes Relat Dis. 2013;9(6):1008-12.